{
  "legislationId": "119_HR_7936",
  "lastUpdate": "2026-04-01T11:16:53.636Z",
  "history": [
    {
      "timestamp": "2026-04-01T11:16:53.636Z",
      "source_url": "https://www.congress.gov/119/bills/hr7936/BILLS-119hr7936ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7936 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7936 To amend the Energy Policy Act of 2005 to support the development, demonstration, and commercial application of biotechnology products to increase energy resiliency, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 16, 2026 Mr. Baird (for himself, Ms. Houlahan, Mrs. Bice, and Mr. Khanna) introduced the following bill; which was referred to the Committee on Science, Space, and Technology _______________________________________________________________________ A BILL To amend the Energy Policy Act of 2005 to support the development, demonstration, and commercial application of biotechnology products to increase energy resiliency, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026''. SEC. 2. SENSE OF CONGRESS. It is the sense of Congress that-- (1) the biggest roadblock for United States biotechnology innovators to commercialization is proving that their products and processes can scale, thus showing investors a path to financial return; (2) the United States faces several main challenges to securing the broad range of infrastructure needed for the breadth of products that biotechnology can make, which are that-- (A) the United States lacks sufficient biomanufacturing capacity, including because researchers are generating new products faster than manufacturing capacity is increasing and building new facilities is expensive and time-consuming; and (B) biomanufacturing technologies of the future have yet to mature into routine commercial applications, as current biomanufacturing facilities are generally optimized for 1 type of product and are usually not compatible with other products; and (3) to position the United States as a leader in bioindustrial innovation and enable participation in groundbreaking projects through state-of-the-art infrastructure, it is critical to establish technology maturation facilities to provide world-class capabilities. SEC. 3. BIOINDUSTRIAL SCALE-UP FOR SUPPLY CHAINS AND ENERGY RESILIENCY. Section 932 of the Energy Policy Act of 2005 (42 U.S.C. 16232) is amended-- (1) in subsection (a)-- (A) by redesignating paragraphs (1) and (2) as paragraphs (5) and (7), respectively; (B) by inserting before paragraph (5) (as so redesignated) the following: ``(1) Biobased product.--The term `biobased product' has the meaning given the term in section 9001 of the Farm Security and Rural Investment Act of 2002 (7 U.S.C. 8101). ``(2) Bioindustrial manufacturing.--The term `bioindustrial manufacturing' means the use of living organisms, cells, tissues, enzymes, or cell-free systems to produce materials and products for nonpharmaceutical applications. ``(3) Biointermediate.--The term `biointermediate' means an intermediate product that is derived from biomass or waste streams, including carbon oxides. ``(4) Biomanufacturing.--The term `biomanufacturing' means the use of biological systems to produce goods and services at commercial scale.''; (C) by inserting after paragraph (5) (as so redesignated) the following: ``(6) Biotechnology.--The term `biotechnology' means technology that applies to or is enabled by life sciences innovation or product development.''; and (D) by inserting after paragraph (7) (as so redesignated) the following: ``(8) Open access.--The term `open access', with respect to infrastructure, data, or research resources, means that those resources are-- ``(A) available without licensing or intellectual property barriers; and ``(B) accessible to public and private entities on an equitable basis. ``(9) Phytobiome.--The term `phytobiome' means a network of interactions of plants, their associated communities of organisms, and their environmental context. ``(10) Technology maturation.--The term `technology maturation' means the development, testing, and scaling of technologies to a level of readiness suitable for commercialization or integration into industrial processes, including activities such as prototyping, pilot-scale testing and demonstration, and early-stage manufacturing and market entry. ``(11) Waste stream.--The term `waste stream' includes municipal solid waste, food waste, urban wood waste, food processing and fermentation waste, sewage, biogas, industrial waste gases, carbon oxides, atmospheric oxides, and waste gases that are effluents or byproduct streams from various societal pursuits that are targeted toward disposal, discharge, or burning.''; and (2) by inserting after subsection (e) the following: ``(f) Bioindustrial Technology Maturation Facilities.-- ``(1) In general.--Not later than September 30, 2030, the Secretary shall establish not fewer than 2 bioindustrial technology maturation facilities (referred to in this subsection as `covered facilities')-- ``(A) to conduct research, development, demonstration, and commercial application to derisk product and process technologies for biotechnology- based products relevant to the mission of the Department; ``(B) that are precommercial; and ``(C) that shall operate as user facilities available to governmental and nongovernmental users. ``(2) Considerations.--In determining the number, type, and location of covered facilities to establish, the Secretary shall-- ``(A) consider-- ``(i) the greatest needs of industry and the gaps in current types of infrastructure; ``(ii) unique capabilities that are currently not available anywhere in the world; ``(iii) how the covered facilities may-- ``(I) complement current infrastructure and capabilities, including infrastructure and capabilities of-- ``(aa) the Department, including National Laboratories; ``(bb) the Department of Defense; ``(cc) the Department of Commerce; and ``(dd) other covered facilities; and ``(II) increase production levels by functioning as a connected network, including by ensuring that available fermentation capacity, including of covered facilities and facilities of the Department, covers the full range needed for precommercial scale-up; and ``(iv) how each covered facility aligns with regional and local workforce needs, pre- existing capabilities, the skills required for the proposed biomanufacturing operations, and the potential for regional and local workforce development and job creation; and ``(B) ensure that-- ``(i) covered facilities are in geographically diverse locations-- ``(I) to maximize access to biological material needed as an input to bioindustrial manufacturing processes; ``(II) to leverage available industrial and academic expertise, including workforce and human capital; and ``(III) to leverage relevant domestic infrastructure required to secure supply chains for chemicals and other materials; ``(ii) covered facilities are complementary to each other and any other existing related facilities; and ``(iii) the first covered facility is planned and built within a 2-year time period, and the plan for the second and each subsequent facility is developed while construction occurs on the earlier planned covered facility. ``(3) Activities.--Activities carried out by a covered facility may include the following: ``(A) Conducting pilot and demonstration projects to evaluate bioindustrial manufacturing processes and technologies for customers. ``(B) Conducting activities to scale bioindustrial manufacturing processes and products for scale-up and deployment efforts, and larger, higher, or different levels of production for customers. ``(C) Developing, testing, and implementing applications and tools, including equipment, hardware, software, and algorithms, with industry and academic partners. ``(D) Addressing technical challenges around bioindustrial manufacturing inputs and the technologies and processes that break down or convert biomass, waste streams, and other inputs that are useful to the bioindustrial manufacturing process, biointermediates, or other products. ``(E) Supporting training and workforce development needs in bioindustrial manufacturing. ``(F) Establishing an interoperable, secure, digital infrastructure for collaborative data exchange across entities in the bioindustrial manufacturing community, including government agencies, industry, and academia. ``(G) Developing and implementing digital tools, process security and assurance capabilities, cybersecurity protocols, and best practices for data storage, sharing, and analysis. ``(H) Leveraging data, modeling, and expertise to assist stakeholders in quantifying economic effects of, and future investment strategies relating to, emerging processes and technologies, and incorporating those findings into techno-economic analysis. ``(I) Any other activity that the Secretary determines appropriate. ``(4) Collaboration.--In carrying out the activities described in paragraph (3), a covered facility may-- ``(A) develop and implement policies to ensure open access to the covered facility for public and private sector entities, with a focus on inclusion of rural communities; ``(B) pursue cost-sharing and cofunding arrangements or opportunities with private sector stakeholders to supplement Federal funding and promote financial sustainability; and ``(C) to maximize the impact of the covered facility, coordinate and collaborate with-- ``(i) industry partners, including to identify priority research, development, and demonstration needs; ``(ii) other Department facilities, including National Laboratories; ``(iii) the defense community, including the Department of Defense and BioMADE; ``(iv) the agricultural community and relevant Federal agencies, including the Department of Agriculture; ``(v) the transportation sector and relevant Federal agencies, including the Department of Transportation; ``(vi) other Federal agencies, including the Department of Commerce, as determined necessary by the covered facility; ``(vii) Federal education and workforce development programs, including the National Science Foundation; ``(viii) institutions of higher education; ``(ix) rural community stakeholders; ``(x) nonprofit organizations; ``(xi) State and local governments; and ``(xii) international bodies with relevant scientific expertise. ``(5) Request for information.--Not later than 90 days after the date of enactment of the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026, the Secretary shall publish a request for information that shall be used by the Secretary to evaluate-- ``(A) existing and planned bioindustrial technology maturation facilities in the United States, including facilities with gas fermentation technologies and large-scale fermentation tanks with robust sensor suites; ``(B) best practices for collaboration at those facilities; and ``(C) any other information determined necessary for the development of the strategic plan under paragraph (6). ``(6) Strategic plan.--Not later than 180 days after the date of enactment of the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026, the Secretary shall submit to the relevant congressional committees a strategic plan for the implementation of this subsection that includes-- ``(A) an assessment of capacity scaling needs to determine what type of additional technology maturation facilities are needed; ``(B) a description of the type, size, and location of each covered facility that the Secretary intends to establish; ``(C) the total number of covered facilities that the Secretary intends to establish; ``(D) the timelines associated with planning and execution of each covered facility, phased over time; and ``(E) a general description of-- ``(i) the focus of each covered facility, including the types of manufacturing equipment, if any, that are expected to be procured for each covered facility; ``(ii) how covered facilities will work as a network to maximize the variety of bioindustrial products available to be produced by the network, including how the capabilities of covered facilities will complement the capabilities of existing and planned technology maturation facilities, including those of other Federal agencies, including the Department of Commerce and the Department of Defense; ``(iii) how that network will support the establishment and maintenance of the bioindustrial manufacturing industrial base; ``(iv) how the Secretary intends to ensure that data is collected and shared with the rest of that network, as applicable; and ``(v) how the Secretary intends to coordinate with other Federal agencies, including the Department of Commerce and the Department of Defense, to ensure the effective use of funds, development of capabilities, and prioritization of biotechnologies. ``(7) Intellectual property protections.-- ``(A) Federal employee contributions.--Any intellectual property created by a Federal employee at a covered facility in the performance of the duties of that Federal employee shall be considered to be part of the public domain. ``(B) Other entities.--Any intellectual property created by an individual at a covered facility who is not a Federal employee shall be protected under applicable intellectual property laws, subject to the terms of the contractual agreement that the individual has entered into with the Secretary. ``(C) Data sharing.--To the maximum extent practicable, a covered facility shall establish a secure, interoperable digital system to facilitate data exchange across government, academia, and industry. ``(8) Report to congress.--Not later than 1 year after the date of enactment of the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026, and at least once every year thereafter for the following 7 years, the Secretary shall submit to the relevant congressional committees, and make publicly available, a report on the activities carried out under this subsection during the year covered by the report, including the progress made in implementing the strategic plan under paragraph (6), including-- ``(A) the number of existing covered facilities; ``(B) the number of additional covered facilities being planned, if any; ``(C) a description of the activities carried out by covered facilities; and ``(D) any collaborations under paragraph (4). ``(9) Authorization of appropriations.--There is authorized to be appropriated to the Secretary to carry out this subsection $225,500,000 for the period of fiscal years 2026 through 2030.''. SEC. 4. TECHNICAL CORRECTION. The table of contents of the Energy Policy Act of 2005 (Public Law 109-58; 119 Stat. 594) is amended by inserting after the item relating to section 1 the following: ``Sec. 2. Definitions.''. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Bioindustrial Scale-Up Act: Boosting Energy Resiliency Through New Biotech Facilities\nSummary: This bill aims to build new facilities that help turn biological research into real-world products like fuels and materials. It focuses on creating jobs and making the country less dependent on foreign supply chains.\nKey Points: Establishment of at least two major bio-manufacturing centers by 2030., Helping innovators scale up their products from the lab to commercial markets., Using waste and plant materials to produce energy and industrial goods., Focus on regional job creation and specialized workforce training., Allocation of $225.5 million to strengthen domestic supply chains and energy security.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": true,\n  \"issue\": \"none\"\n}"
    },
    {
      "timestamp": "2026-04-01T11:13:09.233Z",
      "source_url": "https://www.congress.gov/119/bills/hr7936/BILLS-119hr7936ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7936 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7936 To amend the Energy Policy Act of 2005 to support the development, demonstration, and commercial application of biotechnology products to increase energy resiliency, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 16, 2026 Mr. Baird (for himself, Ms. Houlahan, Mrs. Bice, and Mr. Khanna) introduced the following bill; which was referred to the Committee on Science, Space, and Technology _______________________________________________________________________ A BILL To amend the Energy Policy Act of 2005 to support the development, demonstration, and commercial application of biotechnology products to increase energy resiliency, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026''. SEC. 2. SENSE OF CONGRESS. It is the sense of Congress that-- (1) the biggest roadblock for United States biotechnology innovators to commercialization is proving that their products and processes can scale, thus showing investors a path to financial return; (2) the United States faces several main challenges to securing the broad range of infrastructure needed for the breadth of products that biotechnology can make, which are that-- (A) the United States lacks sufficient biomanufacturing capacity, including because researchers are generating new products faster than manufacturing capacity is increasing and building new facilities is expensive and time-consuming; and (B) biomanufacturing technologies of the future have yet to mature into routine commercial applications, as current biomanufacturing facilities are generally optimized for 1 type of product and are usually not compatible with other products; and (3) to position the United States as a leader in bioindustrial innovation and enable participation in groundbreaking projects through state-of-the-art infrastructure, it is critical to establish technology maturation facilities to provide world-class capabilities. SEC. 3. BIOINDUSTRIAL SCALE-UP FOR SUPPLY CHAINS AND ENERGY RESILIENCY. Section 932 of the Energy Policy Act of 2005 (42 U.S.C. 16232) is amended-- (1) in subsection (a)-- (A) by redesignating paragraphs (1) and (2) as paragraphs (5) and (7), respectively; (B) by inserting before paragraph (5) (as so redesignated) the following: ``(1) Biobased product.--The term `biobased product' has the meaning given the term in section 9001 of the Farm Security and Rural Investment Act of 2002 (7 U.S.C. 8101). ``(2) Bioindustrial manufacturing.--The term `bioindustrial manufacturing' means the use of living organisms, cells, tissues, enzymes, or cell-free systems to produce materials and products for nonpharmaceutical applications. ``(3) Biointermediate.--The term `biointermediate' means an intermediate product that is derived from biomass or waste streams, including carbon oxides. ``(4) Biomanufacturing.--The term `biomanufacturing' means the use of biological systems to produce goods and services at commercial scale.''; (C) by inserting after paragraph (5) (as so redesignated) the following: ``(6) Biotechnology.--The term `biotechnology' means technology that applies to or is enabled by life sciences innovation or product development.''; and (D) by inserting after paragraph (7) (as so redesignated) the following: ``(8) Open access.--The term `open access', with respect to infrastructure, data, or research resources, means that those resources are-- ``(A) available without licensing or intellectual property barriers; and ``(B) accessible to public and private entities on an equitable basis. ``(9) Phytobiome.--The term `phytobiome' means a network of interactions of plants, their associated communities of organisms, and their environmental context. ``(10) Technology maturation.--The term `technology maturation' means the development, testing, and scaling of technologies to a level of readiness suitable for commercialization or integration into industrial processes, including activities such as prototyping, pilot-scale testing and demonstration, and early-stage manufacturing and market entry. ``(11) Waste stream.--The term `waste stream' includes municipal solid waste, food waste, urban wood waste, food processing and fermentation waste, sewage, biogas, industrial waste gases, carbon oxides, atmospheric oxides, and waste gases that are effluents or byproduct streams from various societal pursuits that are targeted toward disposal, discharge, or burning.''; and (2) by inserting after subsection (e) the following: ``(f) Bioindustrial Technology Maturation Facilities.-- ``(1) In general.--Not later than September 30, 2030, the Secretary shall establish not fewer than 2 bioindustrial technology maturation facilities (referred to in this subsection as `covered facilities')-- ``(A) to conduct research, development, demonstration, and commercial application to derisk product and process technologies for biotechnology- based products relevant to the mission of the Department; ``(B) that are precommercial; and ``(C) that shall operate as user facilities available to governmental and nongovernmental users. ``(2) Considerations.--In determining the number, type, and location of covered facilities to establish, the Secretary shall-- ``(A) consider-- ``(i) the greatest needs of industry and the gaps in current types of infrastructure; ``(ii) unique capabilities that are currently not available anywhere in the world; ``(iii) how the covered facilities may-- ``(I) complement current infrastructure and capabilities, including infrastructure and capabilities of-- ``(aa) the Department, including National Laboratories; ``(bb) the Department of Defense; ``(cc) the Department of Commerce; and ``(dd) other covered facilities; and ``(II) increase production levels by functioning as a connected network, including by ensuring that available fermentation capacity, including of covered facilities and facilities of the Department, covers the full range needed for precommercial scale-up; and ``(iv) how each covered facility aligns with regional and local workforce needs, pre- existing capabilities, the skills required for the proposed biomanufacturing operations, and the potential for regional and local workforce development and job creation; and ``(B) ensure that-- ``(i) covered facilities are in geographically diverse locations-- ``(I) to maximize access to biological material needed as an input to bioindustrial manufacturing processes; ``(II) to leverage available industrial and academic expertise, including workforce and human capital; and ``(III) to leverage relevant domestic infrastructure required to secure supply chains for chemicals and other materials; ``(ii) covered facilities are complementary to each other and any other existing related facilities; and ``(iii) the first covered facility is planned and built within a 2-year time period, and the plan for the second and each subsequent facility is developed while construction occurs on the earlier planned covered facility. ``(3) Activities.--Activities carried out by a covered facility may include the following: ``(A) Conducting pilot and demonstration projects to evaluate bioindustrial manufacturing processes and technologies for customers. ``(B) Conducting activities to scale bioindustrial manufacturing processes and products for scale-up and deployment efforts, and larger, higher, or different levels of production for customers. ``(C) Developing, testing, and implementing applications and tools, including equipment, hardware, software, and algorithms, with industry and academic partners. ``(D) Addressing technical challenges around bioindustrial manufacturing inputs and the technologies and processes that break down or convert biomass, waste streams, and other inputs that are useful to the bioindustrial manufacturing process, biointermediates, or other products. ``(E) Supporting training and workforce development needs in bioindustrial manufacturing. ``(F) Establishing an interoperable, secure, digital infrastructure for collaborative data exchange across entities in the bioindustrial manufacturing community, including government agencies, industry, and academia. ``(G) Developing and implementing digital tools, process security and assurance capabilities, cybersecurity protocols, and best practices for data storage, sharing, and analysis. ``(H) Leveraging data, modeling, and expertise to assist stakeholders in quantifying economic effects of, and future investment strategies relating to, emerging processes and technologies, and incorporating those findings into techno-economic analysis. ``(I) Any other activity that the Secretary determines appropriate. ``(4) Collaboration.--In carrying out the activities described in paragraph (3), a covered facility may-- ``(A) develop and implement policies to ensure open access to the covered facility for public and private sector entities, with a focus on inclusion of rural communities; ``(B) pursue cost-sharing and cofunding arrangements or opportunities with private sector stakeholders to supplement Federal funding and promote financial sustainability; and ``(C) to maximize the impact of the covered facility, coordinate and collaborate with-- ``(i) industry partners, including to identify priority research, development, and demonstration needs; ``(ii) other Department facilities, including National Laboratories; ``(iii) the defense community, including the Department of Defense and BioMADE; ``(iv) the agricultural community and relevant Federal agencies, including the Department of Agriculture; ``(v) the transportation sector and relevant Federal agencies, including the Department of Transportation; ``(vi) other Federal agencies, including the Department of Commerce, as determined necessary by the covered facility; ``(vii) Federal education and workforce development programs, including the National Science Foundation; ``(viii) institutions of higher education; ``(ix) rural community stakeholders; ``(x) nonprofit organizations; ``(xi) State and local governments; and ``(xii) international bodies with relevant scientific expertise. ``(5) Request for information.--Not later than 90 days after the date of enactment of the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026, the Secretary shall publish a request for information that shall be used by the Secretary to evaluate-- ``(A) existing and planned bioindustrial technology maturation facilities in the United States, including facilities with gas fermentation technologies and large-scale fermentation tanks with robust sensor suites; ``(B) best practices for collaboration at those facilities; and ``(C) any other information determined necessary for the development of the strategic plan under paragraph (6). ``(6) Strategic plan.--Not later than 180 days after the date of enactment of the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026, the Secretary shall submit to the relevant congressional committees a strategic plan for the implementation of this subsection that includes-- ``(A) an assessment of capacity scaling needs to determine what type of additional technology maturation facilities are needed; ``(B) a description of the type, size, and location of each covered facility that the Secretary intends to establish; ``(C) the total number of covered facilities that the Secretary intends to establish; ``(D) the timelines associated with planning and execution of each covered facility, phased over time; and ``(E) a general description of-- ``(i) the focus of each covered facility, including the types of manufacturing equipment, if any, that are expected to be procured for each covered facility; ``(ii) how covered facilities will work as a network to maximize the variety of bioindustrial products available to be produced by the network, including how the capabilities of covered facilities will complement the capabilities of existing and planned technology maturation facilities, including those of other Federal agencies, including the Department of Commerce and the Department of Defense; ``(iii) how that network will support the establishment and maintenance of the bioindustrial manufacturing industrial base; ``(iv) how the Secretary intends to ensure that data is collected and shared with the rest of that network, as applicable; and ``(v) how the Secretary intends to coordinate with other Federal agencies, including the Department of Commerce and the Department of Defense, to ensure the effective use of funds, development of capabilities, and prioritization of biotechnologies. ``(7) Intellectual property protections.-- ``(A) Federal employee contributions.--Any intellectual property created by a Federal employee at a covered facility in the performance of the duties of that Federal employee shall be considered to be part of the public domain. ``(B) Other entities.--Any intellectual property created by an individual at a covered facility who is not a Federal employee shall be protected under applicable intellectual property laws, subject to the terms of the contractual agreement that the individual has entered into with the Secretary. ``(C) Data sharing.--To the maximum extent practicable, a covered facility shall establish a secure, interoperable digital system to facilitate data exchange across government, academia, and industry. ``(8) Report to congress.--Not later than 1 year after the date of enactment of the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026, and at least once every year thereafter for the following 7 years, the Secretary shall submit to the relevant congressional committees, and make publicly available, a report on the activities carried out under this subsection during the year covered by the report, including the progress made in implementing the strategic plan under paragraph (6), including-- ``(A) the number of existing covered facilities; ``(B) the number of additional covered facilities being planned, if any; ``(C) a description of the activities carried out by covered facilities; and ``(D) any collaborations under paragraph (4). ``(9) Authorization of appropriations.--There is authorized to be appropriated to the Secretary to carry out this subsection $225,500,000 for the period of fiscal years 2026 through 2030.''. SEC. 4. TECHNICAL CORRECTION. The table of contents of the Energy Policy Act of 2005 (Public Law 109-58; 119 Stat. 594) is amended by inserting after the item relating to section 1 the following: ``Sec. 2. Definitions.''. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Rozwój bioprzemysłu: nowe fabryki i technologie dla bezpieczeństwa energetycznego USA\",\n  \"pl_summary\": \"Ustawa zakłada budowę nowoczesnych centrów badawczych, które pomogą przekształcać innowacje biologiczne w gotowe produkty rynkowe. Dzięki temu powstaną nowe miejsca pracy, a kraj stanie się bardziej niezależny energetycznie i surowcowo.\",\n  \"pl_key_points\": [\n    \"Budowa co najmniej dwóch dużych ośrodków testowania technologii bioprzemysłowych do 2030 roku.\",\n    \"Wsparcie dla firm w przenoszeniu pomysłów z laboratoriów do masowej produkcji komercyjnej.\",\n    \"Wykorzystanie odpadów i surowców roślinnych do tworzenia nowych materiałów, paliw i produktów.\",\n    \"Tworzenie nowych miejsc pracy w regionach oraz specjalistyczne szkolenia dla pracowników nowoczesnego przemysłu.\",\n    \"Przeznaczenie ponad 225 milionów dolarów na rozwój technologii zwiększających odporność łańcuchów dostaw.\"\n  ],\n  \"eng_ai_title\": \"Bioindustrial Scale-Up Act: Boosting Energy Resiliency Through New Biotech Facilities\",\n  \"eng_summary\": \"This bill aims to build new facilities that help turn biological research into real-world products like fuels and materials. It focuses on creating jobs and making the country less dependent on foreign supply chains.\",\n  \"eng_key_points\": [\n    \"Establishment of at least two major bio-manufacturing centers by 2030.\",\n    \"Helping innovators scale up their products from the lab to commercial markets.\",\n    \"Using waste and plant materials to produce energy and industrial goods.\",\n    \"Focus on regional job creation and specialized workforce training.\",\n    \"Allocation of $225.5 million to strengthen domestic supply chains and energy security.\"\n  ],\n  \"de_ai_title\": \"Bioindustrie-Ausbaugesetz: Neue Anlagen für Energiesicherheit und biotechnologische Innovationen\",\n  \"de_summary\": \"Dieses Gesetz sieht den Bau neuer Forschungs- und Produktionszentren vor, um biologische Innovationen schneller marktreif zu machen. Ziel ist es, die Abhängigkeit von Importen zu verringern und neue Arbeitsplätze in der modernen Industrie zu schaffen.\",\n  \"de_key_points\": [\n    \"Bau von mindestens zwei großen Zentren für bioindustrielle Technologien bis 2030.\",\n    \"Unterstützung für Unternehmen beim Übergang vom Labor zur Massenproduktion.\",\n    \"Nutzung von Abfällen und Biomasse zur Herstellung neuer Materialien und Energieträger.\",\n    \"Förderung der regionalen Wirtschaft und Ausbildung von Fachkräften.\",\n    \"Bereitstellung von 225,5 Millionen Dollar zur Stärkung der heimischen Lieferketten.\"\n  ],\n  \"fr_ai_title\": \"Loi sur l'expansion bioindustrielle : nouvelles infrastructures pour la résilience énergétique\",\n  \"fr_summary\": \"Cette loi prévoit la création de centres de recherche pour transformer les découvertes biologiques en produits commerciaux concrets. Elle vise à renforcer l'indépendance énergétique et à créer des emplois qualifiés dans les régions.\",\n  \"fr_key_points\": [\n    \"Création d'au moins deux centres de maturation technologique bioindustrielle d'ici 2030.\",\n    \"Aide aux entreprises pour passer du stade de laboratoire à la production industrielle.\",\n    \"Transformation des déchets et de la biomasse en nouveaux matériaux et sources d'énergie.\",\n    \"Soutien au développement de la main-d'œuvre locale et à la création d'emplois.\",\n    \"Investissement de 225,5 millions de dollars pour sécuriser les chaînes d'approvisionnement.\"\n  ],\n  \"es_ai_title\": \"Ley de Escalamiento Bioindustrial: Nuevas instalaciones para la seguridad energética y tecnológica\",\n  \"es_summary\": \"Esta ley busca construir centros de investigación para convertir innovaciones biológicas en productos comerciales reales. El objetivo es fortalecer la independencia energética y generar nuevos empleos en diversas regiones.\",\n  \"es_key_points\": [\n    \"Creación de al menos dos centros de maduración tecnológica bioindustrial para 2030.\",\n    \"Apoyo a innovadores para llevar sus productos del laboratorio al mercado masivo.\",\n    \"Uso de residuos y biomasa para producir materiales y energía de forma sostenible.\",\n    \"Fomento del empleo regional y capacitación técnica para trabajadores.\",\n    \"Asignación de 225,5 millones de dólares para asegurar las cadenas de suministro nacionales.\"\n  ],\n  \"it_ai_title\": \"Legge sullo sviluppo bioindustriale: nuovi impianti per la resilienza energetica e l'innovazione\",\n  \"it_summary\": \"Questa legge prevede la creazione di centri di ricerca per trasformare le scoperte biologiche in prodotti pronti per il mercato. L'obiettivo è aumentare l'indipendenza energetica e creare nuovi posti di lavoro specializzati.\",\n  \"it_key_points\": [\n    \"Istituzione di almeno due centri di maturazione tecnologica bioindustriale entro il 2030.\",\n    \"Supporto alle imprese nel passaggio dalla fase di laboratorio alla produzione su larga scala.\",\n    \"Utilizzo di rifiuti e biomasse per la produzione di nuovi materiali ed energia.\",\n    \"Promozione dell'occupazione locale e della formazione professionale nel settore.\",\n    \"Stanziamento di 225,5 milioni di dollari per rafforzare le catene di approvvigionamento.\"\n  ],\n  \"nl_ai_title\": \"Wet op bio-industriële opschaling: nieuwe faciliteiten voor energiezekerheid en innovatie\",\n  \"nl_summary\": \"Deze wet regelt de bouw van nieuwe onderzoekscentra om biologische innovaties sneller naar de markt te brengen. Het doel is om de energieonafhankelijkheid te vergroten en nieuwe banen te creëren in de moderne industrie.\",\n  \"nl_key_points\": [\n    \"Bouw van ten minste twee grote centra voor bio-industriële technologie tegen 2030.\",\n    \"Hulp aan bedrijven bij de overstap van laboratorium naar massaproductie.\",\n    \"Gebruik van afval en biomassa voor het maken van nieuwe materialen en brandstoffen.\",\n    \"Focus op regionale werkgelegenheid en opleiding van gespecialiseerd personeel.\",\n    \"Investering van 225,5 miljoen dollar om de binnenlandse toeleveringsketens te versterken.\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Criação de pelo menos dois centros de maturação tecnológica bioindustrial até 2030.\",\n    \"Apoio a empresas para levar produtos do laboratório para a produção em larga escala.\",\n    \"Uso de resíduos e biomassa para produzir novos materiais e fontes de energia.\",\n    \"Fomento ao emprego regional e formação de mão de obra especializada.\",\n    \"Alocação de 225,5 milhões de dólares para garantir a segurança das cadeias de suprimentos.\"\n  ],\n  \"category\": [\n    \"Economy\",\n    \"Environment\",\n    \"Public Investments\"\n  ]\n}"
    }
  ]
}